Yttrium-90 DOTATOC: First clinical results

European Journal of Nuclear Medicine

Volumn 26, Issue 11, 1999, Pages 1439-1447

  Otte, A ^a,b   Herrmann, R ^a   Heppeler, A ^a   Behe, M ^a   Jermann, E ^a   Powell, P ^a   Maecke, H R ^a   Muller, J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE   (Germany)

Author keywords

Bone marrow irradiation; DOTA D Phe1 Tyr3 octreotide (DOTATOC); Indium 111; Nephrotoxicity; Somatostatin receptor mediated internal radiotherapy; Yttrium 90

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE N,N,N,N TETRAACETIC ACID OCTREOTIDE[1 DEXTRO PHENYLALANINE 3 TYROSINE]; AMINO ACID; HARTMANN SOLUTION; INDIUM 111; LIVER ENZYME; OCTREOTIDE; PENTETREOTIDE; SOMATOSTATIN RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG; YTTRIUM 90;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; MALE; NEPHROTOXICITY; PATIENT MONITORING; RADIATION DOSE; RADIATION RESPONSE; REMISSION; SCINTIGRAPHY; THROMBOCYTOPENIA; TUMOR GROWTH; TUMOR REGRESSION;

ADULT; AGED; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASMS; OCTREOTIDE; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; YTTRIUM RADIOISOTOPES;

EID: 0032725922     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050476     Document Type: Article

References (10)

1. Patel YC, Amherdt M, Orci L. Quantitative electron microscopic autoradiography of insulin, glucagon and somatostatin binding sites on islets. Science 1982; 217:1155-1156.
2. Reubi JC, Maurer R. Autoradiographic mapping of somatostatin receptors in the rat CNS and pituitary. Neuroscience 1985; 15: 1183-1193.
3. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin-receptor scintigraphy. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press; 1995: 1-50.
4. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
5. Heppeler A, Froidevaux S, Maecke HR, Jermann E, Behe M, Powell P, Hennig M. Radiometal labelled macrolytic chelator derivatised somatostatin analogue with superb tumour targeting properties and potential for receptor mediated internal radiotherapy. Chem Eur J 1999; in press.
6. Otte A, Jermann E, Behe M, Goetze M, Bucher HC, Roser HW, Heppeler A, Mueller-Brand J, Maecke HR. DOTATOC - a powerful new tool for receptor-mediated radionuclide therapy. Eur J Nucl Med 1997; 24: 792-795.
7. Otte A, Mueller-Brand J, Dellas S, Nitzsche EU, Herrmann R, Maecke HR. Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet 1998; 351: 417-418.
8. Behr TM, Sharkey RM, Sgouros G, Blumenthal RD, Dunn RM, Kolbert K, Griffiths GL, Becker WS, Goldenberg DM. Overcoming the nephrotoxicity of radiometal-labelled immunoconjugates. Cancer 1997; 80 (Suppl): 2591-2610.
9. Mogensen CE, Solling K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand J Clin Lab Invest 1977; 37: 477-486.
10. Morant J, Ruppaner H, eds. Arzneimittelkompendium der Schweiz 1997. Basel: Documed AG, 1996.